Options to optimize the access to biosimilars: analysis and solutions
The cost of medical care has been growing around the world; this is due to a number of factors, including the growing use of costly medicines for cancer and rare (orphan) diseases. The introduction of reproduced medicinal products instead of original ones opens the way to medical cost reduction. In...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Buch |
Veröffentlicht: |
IRBIS LLC,
2018-05-01T00:00:00Z.
|
Schlagworte: | |
Online-Zugang: | Connect to this object online. |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Online
Connect to this object online.3rd Floor Main Library
Signatur: |
A1234.567 |
---|---|
Exemplar 1 | Verfügbar |